BL Pharmtech Corp. (KOSDAQ:065170)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,720.00
+625.00 (29.83%)
At close: Sep 11, 2026

BL Pharmtech Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
3,0906,5068,80624,52522,52384,440
Other Revenue
-0-0-0---0
3,0906,5068,80624,52522,52384,440
Revenue Growth
-64.20%-26.12%-64.10%8.89%-73.33%28.54%
Cost of Revenue
1,9442,8142,88510,9649,80163,367
Gross Profit
1,1463,6925,92113,56112,72221,073
Selling, General & Admin
3,6555,9618,28719,47316,82524,014
Amortization of Goodwill & Intangibles
23.07148.75341.79338.08--
Operating Expenses
2,3515,72410,26520,68017,51024,668
Operating Income
-1,205-2,032-4,345-7,119-4,789-3,595
Interest Expense
-604.14-899.73-829.33-1,573-2,206-2,591
Interest & Investment Income
277.06259.12302.4651.42131.12103
Earnings From Equity Investments
-10,426-10,651-1,668-469.42-358.97-51.29
Currency Exchange Gain (Loss)
148.6-31.0724.389.5664.6-374.37
Other Non Operating Income (Expenses)
-722.93-27.961,638-2,854-2,079-1,012
EBT Excluding Unusual Items
-12,533-13,383-4,877-11,955-9,237-7,521
Gain (Loss) on Sale of Investments
-3,280-3,262-17.56-283.867.12
Gain (Loss) on Sale of Assets
-28.42.3478.6653.01-3,084
Asset Writedown
---950-2,900-5,151-16,238
Other Unusual Items
-138.28-138.28-944.7831.0438.48
Pretax Income
-15,980-16,781-5,766-13,856-14,073-20,570
Income Tax Expense
30.625.94-49.36-46.23363.26-462.69
Earnings From Continuing Operations
-16,010-16,787-5,717-13,810-14,437-20,107
Earnings From Discontinued Operations
---13,952787.1-
Net Income to Company
-16,010-16,787-5,717141.63-13,649-20,107
Minority Interest in Earnings
6.919.6310.4-290.47-253.65-104.49
Net Income
-16,003-16,778-5,706-148.85-13,903-20,211
Net Income to Common
-16,003-16,778-5,706-148.85-13,903-20,211
Net Income Growth
------
Shares Outstanding (Basic)
272727272726
Shares Outstanding (Diluted)
272727272726
Shares Change
12.01%0.05%-0.09%-1.33%18.44%
EPS (Basic)
-598.61-628.85-214.00-5.58-520.90-767.32
EPS (Diluted)
-598.61-628.85-214.00-5.58-520.90-767.32
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1,343-283.76-4,2037,680-12,7062,510
Free Cash Flow Per Share
-50.23-10.64-157.64287.73-476.0495.28
Gross Margin
37.09%56.74%67.24%55.30%56.48%24.96%
Operating Margin
-39.01%-31.24%-49.34%-29.03%-21.26%-4.26%
Profit Margin
-517.91%-257.89%-64.81%-0.61%-61.73%-23.94%
Free Cash Flow Margin
-43.46%-4.36%-47.74%31.31%-56.41%2.97%
EBITDA
-776.5-1,476-3,492-6,271-3,888-146.75
EBITDA Margin
-25.13%-22.69%-39.66%-25.57%-17.26%-0.17%
D&A For EBITDA
428.93556.32852.35848.1900.553,448
EBIT
-1,205-2,032-4,345-7,119-4,789-3,595
EBIT Margin
-39.01%-31.24%-49.34%-29.03%-21.26%-4.26%
Advertising Expenses
-766.181,6433,6752,2062,535